『Influenza and COVID-19 Multicomponent Vaccine, Procedural-Based Treatments for Mixed Urinary Incontinence, Estimating Reform Impact on the Medicare Advantage Quality Bonus Program, and more』のカバーアート

Influenza and COVID-19 Multicomponent Vaccine, Procedural-Based Treatments for Mixed Urinary Incontinence, Estimating Reform Impact on the Medicare Advantage Quality Bonus Program, and more

Influenza and COVID-19 Multicomponent Vaccine, Procedural-Based Treatments for Mixed Urinary Incontinence, Estimating Reform Impact on the Medicare Advantage Quality Bonus Program, and more

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

Editor’s Summary by Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, and Anne R. Cappola, MD, ScM, Senior Editor at JAMA, for articles published from May 3-9, 2025.

Influenza and COVID-19 Multicomponent Vaccine, Procedural-Based Treatments for Mixed Urinary Incontinence, Estimating Reform Impact on the Medicare Advantage Quality Bonus Program, and moreに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。